Inappropriate therapy for MRSA costly, potentially deadly, problem

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.561, 2008-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potentially inappropriate prescriptions raise costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 597, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Potentially Inappropriate Prescribing in Canada Relative to the US

By Paula A. Rochon

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 939-947

Adis International

Access to resources Recommend Favorite

Failure of initial antibacterial therapy costly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

New onset hyperlipidaemia potentially costly adverse event following renal transplantation

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 365, 2002-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Comparison of Published Explicit Criteria for Potentially Inappropriate Medications in Older Adults

By Chang Chirn-Bin Chan Ding-Cheng

Drugs & Aging, Vol. 27, Iss. 12, 2010-12 ,pp. : 947-957

Adis International

Access to resources Recommend Favorite